UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 8)
Dexterity Surgical, Inc.
_____________________________________________________________________________
(Name of Issuer)
Common Stock
_____________________________________________________________________________
(Title of Class of Securities)
252368105
__________________________
(CUSIP Number)
13G
CUSIP No. 252368105
_____________________________________________________________________________
1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO.
Renaissance Capital Growth & Income Fund III, Inc. 75-2533518
_____________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
(b)
_____________________________________________________________________________
3. SEC USE ONLY
_____________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Texas
_____________________________________________________________________________
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
_____________________________________________________________________________
5. SOLE VOTING POWER
2,346,920 shares
_____________________________________________________________________________
6. SHARED VOTING POWER
None
_____________________________________________________________________________
7. SOLE DISPOSITIVE POWER
2,346,920 shares
_____________________________________________________________________________
8. SHARED DISPOSITIVE POWER
None
_____________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,346,920 shares
_____________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
Not applicable
_____________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
17.25%
_____________________________________________________________________________
12. TYPE OF REPORTING PERSON
IV
_____________________________________________________________________________
ITEM 1.
(a), (b) Dexterity Surgical, Inc. ("Company")
12961 Park Central, Suite 1300
San Antonio, TX 78216
ITEM 2.
(a) Name of Person Filing
Renaissance Capital Growth & Income Fund III, Inc. ("Filer")
(b) Address of principal Business Office or, if none, Residence
8080 N. Central Expressway, Suite 210, LB 59
Dallas, TX 75206-1857
(c) Citizenship
Texas
(d) Title of Class of Securities
Common Stock
(e) CUSIP Number
75966V105
ITEM 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b),
check whether the person filing is a:
(a) ______ Broker or Dealer registered under Section 15 of the Act
(b) ______ Bank as defined in section 3(a)(6) of the Act
(c) ______ Insurance Company as defined in section 3(a)(19) of the Act
(d) X Investment Company registered under section 8 of the Investment
______ Company Act
(e) ______ Investment Adviser registered under section 203 of the Investment
Advisers Act of 1940
(f) ______ Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of 1974
or Endowment Fund; see section 240.13d-1(b)(1)(ii)(F)
(g) ______ Parent Holding Company, in accordance with section 240.13d-1(b)
(ii)(G)(Note: See Item 7)
(h) ______ Group, in accordance with section 240.13d-1(b)(1)(ii)(H)
ITEM 4. Ownership.
(a) Amount Beneficially Owned:
On December 19, 1997, the Company and the Filer entered into a 9%
Convertible Debenture Loan Agreement for $1,500,000 due December 19,
2004, and convertible at $1.60 per share as of April 30, 1999. On
December 19, 1997, the Filer purchased 125,000 shares of the Company's
common stock. On August 11, 1998, the Filer purchased 500 shares at
$1,000 per share of the Company's Series A Cumulative Convertible
Preferred Stock, convertible into common stock at $1.60 per share as of
April 30, 1999. On November 19, 1998, the Filer purchased 500 shares at
$1,000 per share of the Company's Series B Cumulative Convertible
Preferred Stock, convertible into common stock at $1.60 per share as of
April 30, 1999. On March 27, 2000, the $1,500,000 9% Convertible
Debenture was revised to be convertible at $1.00 per share. The
Convertible Loan Agreement was also amended to provide for the payment
of interest from February 1, 2000 through January 31, 2001 in shares of
Common Stock giving the Filer 135,000 shares of the Company's Common
Stock. On June 15, 2000 the conversion price of the Series A and Series
B Convertible Preferred Stock was adjusted to $1.56 per share which
makes the $500,000 of the Company's Series A Cumulative Convertible
Preferred Stock convertible into 320,513 shares of common stock and the
$500,000 of the Company's Series B Cumulative Convertible Preferred
Stock convertible into 320,513 shares of common stock. On Nov. 17, 2000
Robert C. Pearson assigned 5,000 shares of stock options vesting July
27, 2000 with an exercise price of $0.75 per share expiring July 27,
2010 to Renaissance Capital Growth & Income Fund III, Inc. All the
positions are convertible within sixty days. On January 10, 2001, the
Company made a $29,850.00 principal payment bringing the 9% Convertible
Debenture amount to $1,470,150.00. On February 7, 2001, the Company
made a $14,701.50 principal payment bringing the 9% Convertible
Debenture amount to $1,455,448.50. On March 22, 2001, the Company
made a $14,554.49 principal payment bringing the 9% Convertible
Debenture amount to $1,440,894.01. Thus the Filer owns 2,346,920
shares of the Company's common stock on a fully converted basis. The
Investment Advisor is Renaissance Capital Group, Inc., which is also
Investment Manager for Renaissance US Growth and Income Trust PLC.
Renaissance US Growth and Income Trust PLC also owns securities of
Dexterity Surgical, Inc.
(b) Percent of Class
17.25%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
2,346,920 shares
(ii) shared power to vote or to direct the vote: None
(iii) sole power to dispose or to direct the disposition of:
2,346,920 shares
(iv) shared power to dispose or to direct the disposition of: None
ITEM 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of
more than five percent of the class of securities, check the following:
ITEM 6. Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
ITEM 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company.
Not applicable.
ITEM 8. Identification and Classification of Members of the Group.
Not applicable.
ITEM 9. Notice of Dissolution of Group.
Not applicable.
ITEM 10. Certification.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary
course of business and were not acquired for the purpose of and do not
have the effect of changing or influencing the control of the issuer of
such securities and were not acquired in connection with or as a
participant in any transaction having such purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true,
complete and correct.
Date: April 4, 2001 /S/
__________________________________________________
Signature
Russell Cleveland, President & CEO
Renaissance Capital Growth & Income Fund III, Inc.
__________________________________________________
Name and Title